Detalhe da pesquisa
1.
Estrogen receptor ß and 17ß-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
Proc Natl Acad Sci U S A
; 108(50): 20090-4, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22114194
2.
Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
Int J Oncol
; 25(1): 179-85, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15202004
3.
Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.
Int J Oncol
; 25(4): 955-60, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15375545
4.
Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
Int J Mol Med
; 11(4): 529-33, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12632109
5.
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
BMC Med Genomics
; 3: 59, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21162720
6.
Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.
Prostate
; 54(2): 103-11, 2003 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12497583
7.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
Proc Natl Acad Sci U S A
; 101(3): 811-6, 2004 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-14711987